生物活性 | |||
---|---|---|---|
描述 | AZD7624 is an inhaled p38 inhibitor, with potent anti-inflammatory activity. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01817855 | COPD Healthy ... 展开 >>Subjects 收起 << | Phase 1 | Completed | - | United Kingdom ... 展开 >> Research Site London, United Kingdom 收起 << |
NCT02238483 | Chronic Obstructive Pulmonary ... 展开 >>Disease COPD 收起 << | Phase 2 | Completed | - | - |
NCT02753764 | Corticosteroid Resistant (CR) ... 展开 >>Asthmatics 收起 << | Phase 2 | Recruiting | January 2018 | United States, Colorado ... 展开 >> National Jewish Health Recruiting Denver, Colorado, United States, 80206 Sub-Investigator: Elena Goleva, PhD Principal Investigator: Donald Leung, MD, PhD 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.03mL 0.41mL 0.20mL |
10.17mL 2.03mL 1.02mL |
20.34mL 4.07mL 2.03mL |